Brennan TA - Search Results

1

Randomized trial of four financial-incentive programs for smoking cessation.

Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, Loewenstein G, Brennan TA, Asch DA, Volpp KG. Halpern SD, et al. Among authors: brennan ta. N Engl J Med. 2015 May 28;372(22):2108-17. doi: 10.1056/NEJMoa1414293. Epub 2015 May 13. N Engl J Med. 2015. PMID: 25970009 Free PMC article. Clinical Trial.

2

Partners and Alerts in Medication Adherence: A Randomized Clinical Trial.

Kessler JB, Troxel AB, Asch DA, Mehta SJ, Marcus N, Lim R, Zhu J, Shrank W, Brennan T, Volpp KG. Kessler JB, et al. J Gen Intern Med. 2018 Sep;33(9):1536-1542. doi: 10.1007/s11606-018-4389-7. Epub 2018 Mar 15. J Gen Intern Med. 2018. PMID: 29546659 Free PMC article. Clinical Trial.

3

Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.

Barankay I, Reese PP, Putt ME, Russell LB, Loewenstein G, Pagnotti D, Yan J, Zhu J, McGilloway R, Brennan T, Finnerty D, Hoffer K, Chadha S, Volpp KG. Barankay I, et al. JAMA Netw Open. 2020 Oct 1;3(10):e2019429. doi: 10.1001/jamanetworkopen.2020.19429. JAMA Netw Open. 2020. PMID: 33034639 Free PMC article. Clinical Trial.

4

Asymmetric paternalism to improve health behaviors.

Loewenstein G, Brennan T, Volpp KG. Loewenstein G, et al. JAMA. 2007 Nov 28;298(20):2415-7. doi: 10.1001/jama.298.20.2415. JAMA. 2007. PMID: 18042920 No abstract available.

5

Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.

Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoenbaum M, Hutchins D, Brennan T, Loewenstein G. Larkin I, et al. JAMA. 2017 May 2;317(17):1785-1795. doi: 10.1001/jama.2017.4039. JAMA. 2017. PMID: 28464141 Free PMC article.

6

Abusive prescribing of controlled substances--a pharmacy view.

Betses M, Brennan T. Betses M, et al. N Engl J Med. 2013 Sep 12;369(11):989-91. doi: 10.1056/NEJMp1308222. Epub 2013 Aug 21. N Engl J Med. 2013. PMID: 23964897 Free article. No abstract available.

7

Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

Mello MM, Studdert DM, Brennan TA. Mello MM, et al. Among authors: brennan ta. N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695. N Engl J Med. 2009. PMID: 19357413 No abstract available.

8

The role of medical liability reform in federal health care reform.

Mello MM, Brennan TA. Mello MM, et al. Among authors: brennan ta. N Engl J Med. 2009 Jul 2;361(1):1-3. doi: 10.1056/NEJMp0903765. Epub 2009 Jun 15. N Engl J Med. 2009. PMID: 19528190 No abstract available.

9

Obesity--the new frontier of public health law.

Mello MM, Studdert DM, Brennan TA. Mello MM, et al. Among authors: brennan ta. N Engl J Med. 2006 Jun 15;354(24):2601-10. doi: 10.1056/NEJMhpr060227. N Engl J Med. 2006. PMID: 16775242 Free article. No abstract available.

10

The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.

Mello MM, Studdert DM, Brennan TA. Mello MM, et al. Among authors: brennan ta. N Engl J Med. 2004 Feb 5;350(6):608-13. doi: 10.1056/NEJMlim035683. N Engl J Med. 2004. PMID: 14762190 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page